Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-03-20
DOI
10.1002/ejhf.1452
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- P6168Digitoxin serum concentrations affecting patient safety and potential outcome in patients with HFrEF - analyses of the ongoing DIGIT-HF-trial
- (2017) U. Bavendiek et al. EUROPEAN HEART JOURNAL
- Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry
- (2017) Ovidiu Chioncel et al. EUROPEAN JOURNAL OF HEART FAILURE
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Heart failure epidemiology 2000-2013: insights from the German Federal Health Monitoring System
- (2016) Michael Christ et al. EUROPEAN JOURNAL OF HEART FAILURE
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure
- (2016) Nish Patel et al. JACC-Heart Failure
- Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data
- (2015) Oliver J Ziff et al. BMJ-British Medical Journal
- Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data
- (2015) Oliver J Ziff et al. BMJ-British Medical Journal
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure
- (2012) D. Castagno et al. EUROPEAN HEART JOURNAL
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
- (2010) Karl Swedberg et al. LANCET
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Digitoxin elicits anti-inflammatory and vasoprotective properties in endothelial cells: Therapeutic implications for the treatment of atherosclerosis?
- (2009) Joanna Jagielska et al. ATHEROSCLEROSIS
- Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003
- (2009) Pardeep S. Jhund et al. CIRCULATION
- Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
- (2009) Arthur J. Moss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: A propensity-matched study of the DIG trial
- (2007) Ali Ahmed et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started